<div id="readability-page-1"><div id="blog-content">Although the benchmark indices opened lower, they traded negatively throughout the session and ultimately closed in red.Indian equity benchmarks, Sensex and Nifty50, ended flat with a negative bias on Tuesday, as strong buying in PSU bank, metal and auto counters was offset by selling in IT, FMCG, realty and pharma shares.At the closing bell, the BSE Sensex closed lower by 20 points.Meanwhile, the NSE Nifty closed 3 points lower.Tata Steel, M&amp;M, and Bajaj Finserv are among the top gainers today.Infosys, Eternal, HCL Tech, on the other hand, were among the top losers today.The GIFT Nifty was trading at 26,112, higher by 146 points at the time of writing.The BSE MidCap index ended 0.1% lower, and the BSE SmallCap index ended 0.2% lower.Sectoral indices are trading mixed today, with stocks in the healthcare sector and realty sector witnessing selling pressure. Meanwhile, shares in the metal and auto sectors witnessed buying.The rupee is trading at Rs 89.9 against the US$.Gold prices for the latest contract on MCX are trading 1% higher at Rs 136,274 per gram.Meanwhile, silver prices were trading 5% higher at Rs 235,670 per 1 kg. <h3>Mangalam Shares Jump After Kedia Stake</h3>In the news from pharma sector, shares of Mangalam Drugs and Organics came into focus after Kedia Securities bought a stake in the company.NSE bulk deal data showed that Kedia Securities, led by veteran investor Vijay Kedia, bought 1,37,794 shares of Mangalam Drugs and Organics at Rs 24.15 per share. As per the BSE shareholding pattern, promoters held a 50.36% stake in the company as of December 2025.Kedia Securities is Vijay Kedia's investment firm. It invests in both listed companies traded on Indian stock exchanges and unlisted businesses such as startups. The firm also has investments in real estate.Mangalam Drugs and Organics has nearly 50 years of experience and is well known globally for manufacturing key anti-malaria active pharmaceutical ingredients (APIs). Over time, it has expanded into a wide range of products, benefiting from strong scale and operational efficiency. The company is among the leading producers in Asia for several of its products and is the world's largest manufacturer of some of them. <h3>Biocon Tie-Up Boosts Ajanta Pharma Shares</h3>Moving on to the news from pharma sector, shares of Ajanta Pharma came into focus after it entered a strategic partnership with Biocon to source semaglutide for 23 target countries, and semi-exclusive rights in Africa, the Middle East, and Central Asia, marking a meaningful step toward introducing newer therapies in these markets.The company said it has been a pioneer in using a strong field force in some markets. This partnership will help Ajanta Pharma increase its market share for semaglutide.In India, the deal will allow Ajanta to sell certain Biocon products by using its well-established sales network, wide doctor connections, and strong presence in chronic therapy segments. <img height="326" src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="700" original-src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif"/><h3> Defence Digital Win Boosts Silver Touch</h3>Moving on to the news from IT sector, shares of Silver Touch Technologies came into focus after the company was chosen as the Digital Transformation Partner for the Indian Navy under the IPADSV2 initiative.This development is positive for the company as it strengthens its defence business and is expected to provide steady revenue and order growth over the coming years.As part of the project, Silver Touch will build a digital platform for the Indian Navy to improve automation, efficiency, and secure operations. The platform will help manage personnel records, leave and travel approvals, assets and inventory, and provide real-time reports and dashboards. It will also connect with other Navy systems, ensure secure access based on roles, and maintain proper document records and audit trails.The cloud-based and mobile-friendly system will support critical Navy operations while improving long-term efficiency and scalability.Silver Touch Technologies is a fast-growing IT services company that provides technology, consulting, and business process solutions. It uses advanced technologies such as AI, automation, cloud, and analytics to help organizations modernize and succeed in the digital age.<hr/>More By This Author:Nifty Below 25,950; Tata Steel &amp; Bajaj Finance Top Losers Sensex Today Ends 345 Points Lower; Nifty Below 25,950 Sensex Today Trades Flat; Nifty Below 26,100</div></div>

INFY

The Indian equity benchmarks, Sensex and Nifty50, closed lower with a negative bias, influenced by selling in IT, FMCG, realty, and pharma sectors, despite gains in PSU banks, metals, and autos. Infosys, Eternal, and HCL Tech were among the top losers, while Tata Steel and M&M gained. The rupee traded at Rs 89.9 against the US dollar. In the pharma sector, Mangalam Drugs saw a stake purchase by Kedia Securities, and Ajanta Pharma partnered with Biocon for semaglutide distribution. Silver Touch Technologies was selected as a digital partner for the Indian Navy, enhancing its defense business.

Nifty Below 25,950; Infosys & Internal Top Losers